Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.

Protein biopharmaceuticals such as monoclonal antibodies and therapeutic proteins are currently in widespread use for the treatment of various life-threatening diseases including cancer, autoimmune disorders, diabetes and anemia. The complexity of protein therapeutics is far exceeding that of small molecule drugs; hence, unraveling this complexity represents an analytical challenge. The current review provides the reader with state-of-the-art chromatographic and mass spectrometric tools available to dissect primary and higher order structures, post-translational modifications, purity and impurity profiles and pharmacokinetic properties of protein therapeutics.

[1]  R. Chance,et al.  Research, Development, Production, and Safety of Biosynthetic Human Insulin , 1993, Diabetes Care.

[2]  Alain Balland,et al.  Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. , 2008, Journal of chromatography. A.

[3]  A. Meager,et al.  Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method. , 2013, Journal of pharmaceutical and biomedical analysis.

[4]  Damian J. Houde,et al.  Conformational analysis of recombinant monoclonal antibodies with hydrogen/deuterium exchange mass spectrometry. , 2013, Methods in molecular biology.

[5]  Pauline M Rudd,et al.  An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture. , 2013, Analytical biochemistry.

[6]  S. Rudaz,et al.  Analysis of recombinant monoclonal antibodies by RPLC: toward a generic method development approach. , 2012, Journal of pharmaceutical and biomedical analysis.

[7]  Hongwei Xie,et al.  Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry. , 2011, Analytical biochemistry.

[8]  Margaret Ricci,et al.  The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. , 2007, Journal of pharmaceutical sciences.

[9]  Quynh-Thu Le,et al.  Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. , 2008, The New England journal of medicine.

[10]  P. Rudd,et al.  Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  P. Carter,et al.  Introduction to current and future protein therapeutics: a protein engineering perspective. , 2011, Experimental cell research.

[12]  M. Tarlov,et al.  Electrospray-differential mobility analysis as an orthogonal tool to size-exclusion chromatography for characterization of protein aggregates. , 2012, Journal of pharmaceutical sciences.

[13]  B. Karger,et al.  Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry. , 2010, Analytical chemistry.

[14]  V. Katta,et al.  Detecting low level sequence variants in recombinant monoclonal antibodies , 2010, mAbs.

[15]  Vasco Filipe,et al.  Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography , 2010, Pharmaceutical Research.

[16]  Bettina Warscheid,et al.  Top-down de Novo protein sequencing of a 13.6 kDa camelid single heavy chain antibody by matrix-assisted laser desorption ionization-time-of-flight/time-of-flight mass spectrometry. , 2010, Analytical chemistry.

[17]  John F. Valliere-Douglass,et al.  Molecular mass analysis of antibodies by on-line SEC-MS , 2008, Journal of the American Society for Mass Spectrometry.

[18]  W. Jelkmann Recombinant EPO production--points the nephrologist should know. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  S. Berkowitz,et al.  Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. , 2009, Analytical chemistry.

[20]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2007 , 2008, Nature Biotechnology.

[21]  Hendrik Neubert,et al.  Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. , 2013, Analytical chemistry.

[22]  B. Yan,et al.  Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. , 2007, Journal of chromatography. A.

[23]  Alain Van Dorsselaer,et al.  Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  Y. Lou,et al.  Development of capillary size exclusion chromatography for the analysis of monoclonal antibody fragments extracted from human vitreous humor. , 2012, Journal of chromatography. A.

[25]  Yehia Mechref,et al.  Comprehensive assessment of N‐glycans derived from a murine monoclonal antibody: A case for multimethodological approach , 2005, Electrophoresis.

[26]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2006 , 2006, Nature Biotechnology.

[27]  Difei Qiu,et al.  C‐terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes , 2008, Biotechnology and bioengineering.

[28]  C. F. van der Walle,et al.  Therapeutic antibodies: market considerations, disease targets and bioprocessing. , 2013, International journal of pharmaceutics.

[29]  M. Macht Top-down characterization of biopharmaceuticals , 2013 .

[30]  B. Karger,et al.  2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions. , 2011, Analytical chemistry.

[31]  S. Alley,et al.  Analytical and bioanalytical technologies for characterizing antibody-drug conjugates. , 2013, Current opinion in chemical biology.

[32]  J. Hubbuch,et al.  A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatography. , 2011, Journal of chromatography. A.

[33]  Saurabh Aggarwal,et al.  What's fueling the biotech engine? , 2007, Nature Biotechnology.

[34]  Qiang Qin,et al.  High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry. , 2009, Analytical biochemistry.

[35]  H. Dewald,et al.  Electrochemistry-assisted top-down characterization of disulfide-containing proteins. , 2012, Analytical chemistry.

[36]  P. V. van Berkel,et al.  Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.

[37]  A. Raghani,et al.  Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide. , 2010, Analytical biochemistry.

[38]  W. Sly,et al.  Identification of N-glycans displaying mannose-6-phosphate and their site of attachment on therapeutic enzymes for lysosomal storage disorder treatment. , 2011, Analytical chemistry.

[39]  C. Damen,et al.  Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab , 2009, Journal of the American Society for Mass Spectrometry.

[40]  Saurabh Aggarwal,et al.  What's fueling the biotech engine--2010 to 2011. , 2011, Nature biotechnology.

[41]  R. F. Latypov,et al.  Nondenaturing size-exclusion chromatography-mass spectrometry to measure stress-induced aggregation in a complex mixture of monoclonal antibodies. , 2013, Analytical chemistry.

[42]  W. Hancock,et al.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation. , 2011, Analytical chemistry.

[43]  T. Dierks,et al.  Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. Sandra,et al.  Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liquid-based separation techniques. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[45]  Wolfgang Lindner,et al.  Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis. , 2011, Journal of chromatography. A.

[46]  P. Caliceti,et al.  A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[47]  W. Xu,et al.  Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis. , 2012, Analytical chemistry.

[48]  J. R. Engen,et al.  Hydrogen exchange mass spectrometry: what is it and what can it tell us? , 2010, Analytical and bioanalytical chemistry.

[49]  W. Hancock,et al.  Identification of the unpaired cysteine status and complete mapping of the 17 disulfides of recombinant tissue plasminogen activator using LC-MS with electron transfer dissociation/collision induced dissociation. , 2010, Analytical Chemistry.

[50]  Aditya A Wakankar,et al.  Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.

[51]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2011 to 2012 , 2012, Nature Biotechnology.

[52]  André M Deelder,et al.  Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry , 2009, Analytical and bioanalytical chemistry.

[53]  R. F. Latypov,et al.  Characterization of a unique IgG1 mAb CEX profile by limited Lys-C proteolysis/CEX separation coupled with mass spectrometry and structural analysis. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[54]  D. Chelius,et al.  18O labeling method for identification and quantification of succinimide in proteins. , 2007, Analytical chemistry.

[55]  Zheng Ouyang,et al.  A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies. , 2012, Biomedical chromatography : BMC.

[56]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[57]  R. Dwek,et al.  A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.

[58]  Yehia Mechref,et al.  Use of CID/ETD Mass Spectrometry to Analyze Glycopeptides , 2012, Current protocols in protein science.

[59]  Pauline M. Rudd,et al.  GlycoBase and autoGU: tools for HPLC-based glycan analysis , 2008, Bioinform..

[60]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2009–2010 , 2010, Nature Biotechnology.

[61]  Gregory C Flynn,et al.  Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry. , 2007, Analytical biochemistry.

[62]  M. Karas,et al.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.

[63]  R J Harris,et al.  Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. , 1995, Journal of chromatography. A.

[64]  M. C. García,et al.  The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[65]  John F. Valliere-Douglass,et al.  Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.

[66]  David B Volkin,et al.  Analytical lessons learned from selected therapeutic protein drug comparability studies. , 2013, Biologicals : journal of the International Association of Biological Standardization.

[67]  M. Mann,et al.  Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.

[68]  D. Guillarme,et al.  Critical evaluation of fast size exclusion chromatographic separations of protein aggregates, applying sub-2 μm particles. , 2013, Journal of pharmaceutical and biomedical analysis.

[69]  T. Patapoff,et al.  Improving pH gradient cation-exchange chromatography of monoclonal antibodies by controlling ionic strength. , 2013, Journal of chromatography. A.

[70]  Y. Mechref,et al.  Glycomic analysis by capillary electrophoresis-mass spectrometry. , 2009, Mass spectrometry reviews.

[71]  D. Chelius,et al.  Reversed-phase liquid chromatography in-line with negative ionization electrospray mass spectrometry for the characterization of the disulfide-linkages of an immunoglobulin gamma antibody , 2006, Journal of the American Society for Mass Spectrometry.

[72]  Yehia Mechref,et al.  Enzymatic/chemical release of O-glycans allowing MS analysis at high sensitivity. , 2009, Analytical chemistry.

[73]  Lihua Huang,et al.  Epitope mapping of antibodies by mass spectroscopy: a case study. , 2013, Methods in molecular biology.

[74]  Mingxiang Li,et al.  Separation of oxidized variants of a monoclonal antibody by anion-exchange. , 2011, Journal of chromatography. A.

[75]  Damon L. Meyer,et al.  cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. , 2003, Blood.

[76]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.

[77]  F. Sörgel,et al.  Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals , 2013, Analytical and Bioanalytical Chemistry.

[78]  S. Sanglier-Cianférani,et al.  Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. , 2009, Analytical chemistry.

[79]  Jingming Zhang,et al.  Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry , 2013, mAbs.

[80]  A. Lim,et al.  Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. , 2007, Mass spectrometry reviews.

[81]  Reed J. Harris,et al.  Non-enzymatic hinge region fragmentation of antibodies in solution. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[82]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[83]  M F Bean,et al.  Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. , 1993, Analytical chemistry.

[84]  Sheng Yin,et al.  Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates. , 2013, Analytical chemistry.

[85]  Gary Walsh,et al.  Post-translational modifications of protein biopharmaceuticals. , 2009, Drug discovery today.

[86]  Analytical characterization of a novel degradation product in a PEGylated recombinant protein. , 2011, Journal of pharmaceutical sciences.

[87]  Y. Yu,et al.  Using Hydrogen/Deuterium Exchange Mass Spectrometry to Study Conformational Changes in Granulocyte Colony Stimulating Factor upon PEGylation , 2012, Journal of The American Society for Mass Spectrometry.

[88]  Alain Van Dorsselaer,et al.  Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. , 2012, Analytical chemistry.

[89]  Lawrence W. Dick,et al.  Peptide mapping of therapeutic monoclonal antibodies: improvements for increased speed and fewer artifacts. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[90]  D. Guillarme,et al.  Kinetic evaluation of new generation of column packed with 1.3 μm core-shell particles. , 2013, Journal of chromatography. A.

[91]  S. Berkowitz,et al.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. , 2011, Journal of pharmaceutical sciences.

[92]  Guodong Chen,et al.  Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies , 2011, Analytical and Bioanalytical Chemistry.

[93]  M. O'Callaghan,et al.  Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. , 2008, Molecular genetics and metabolism.

[94]  Zhongqi Zhang,et al.  Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. , 2007, Analytical chemistry.

[95]  Y. Mechref,et al.  Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS , 2008, Journal of the American Society for Mass Spectrometry.

[96]  E. Ezan,et al.  Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. , 2008, Analytical chemistry.

[97]  J. Veuthey,et al.  New trends in reversed-phase liquid chromatographic separations of therapeutic peptides and proteins: theory and applications. , 2012, Journal of pharmaceutical and biomedical analysis.

[98]  Surinder Kaur,et al.  Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. , 2011, Analytical biochemistry.

[99]  Ruedi Aebersold,et al.  The Implications of Proteolytic Background for Shotgun Proteomics*S , 2007, Molecular & Cellular Proteomics.

[100]  Ingo H Gorr,et al.  Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach , 2012, PloS one.

[101]  Martin Schiestl,et al.  Acceptable changes in quality attributes of glycosylated biopharmaceuticals , 2011, Nature Biotechnology.

[102]  J. Gebler,et al.  Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry. , 2009, Analytical chemistry.

[103]  M. F. Bean,et al.  Selective identification and differentiation of N‐and O‐linked oligosaccharides in glycoproteins by liquid chromatography‐mass spectrometry , 1993, Protein science : a publication of the Protein Society.

[104]  Hossein Salimi-Moosavi,et al.  General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. , 2012, Analytical chemistry.

[105]  Wei Zhang,et al.  Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody. , 2002, Analytical biochemistry.

[106]  Natalie J. Thompson,et al.  Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry , 2013 .

[107]  André M Deelder,et al.  Glycoproteomics based on tandem mass spectrometry of glycopeptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[108]  William S. Hancock,et al.  Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. , 2009, Analytical chemistry.

[109]  S. Clarke,et al.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.

[110]  Serge Rudaz,et al.  Intact protein analysis in the biopharmaceutical field. , 2011, Journal of pharmaceutical and biomedical analysis.

[111]  Cheng Lin,et al.  Detecting deamidation products in proteins by electron capture dissociation. , 2006, Analytical chemistry.

[112]  Pat Sandra,et al.  Comprehensive liquid chromatography: fundamental aspects and practical considerations--a review. , 2009, Analytica chimica acta.

[113]  C. Beddell,et al.  Mass spectrometry of the humanized monoclonal antibody CAMPATH 1H. , 1995, Analytical chemistry.

[114]  R. Gurny,et al.  New methods allowing the detection of protein aggregates , 2009, mAbs.

[115]  P. Schnier,et al.  Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.

[116]  Y. Lou,et al.  Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal antibody charge variant separations. , 2011, Journal of pharmaceutical and biomedical analysis.

[117]  Hendrik Neubert,et al.  Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS. , 2012, Analytical chemistry.

[118]  C. Scarff,et al.  MALDI-MS/MS with Traveling Wave Ion Mobility for the Structural Analysis of N-Linked Glycans , 2012, Journal of The American Society for Mass Spectrometry.

[119]  Ya-jun Guo,et al.  Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products , 2012, mAbs.

[120]  D. Harvey Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008. , 2012, Mass spectrometry reviews.

[121]  Eric Ezan,et al.  Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. , 2009, Bioanalysis.

[122]  Hongwei Xie,et al.  Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies , 2010, mAbs.

[123]  Olivier Heudi,et al.  Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. , 2008, Analytical chemistry.

[124]  Igor A Kaltashov,et al.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.

[125]  Milos V. Novotny,et al.  High-sensitivity analytical approaches for the structural characterization of glycoproteins. , 2013, Chemical reviews.

[126]  Damian Houde,et al.  Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding* , 2010, Molecular & Cellular Proteomics.

[127]  I. Kaltashov,et al.  Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid‐β‐glucocerebrosidase at near‐physiological pH , 2010, Protein science : a publication of the Protein Society.

[128]  Renate Kunert,et al.  Analysis of immunoglobulin glycosylation by LC‐ESI‐MS of glycopeptides and oligosaccharides , 2008, Proteomics.

[129]  J. Reichert Which are the antibodies to watch in 2012? , 2012, mAbs.

[130]  John R. Engen,et al.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.

[131]  Natalie J. Thompson,et al.  Qualitative and semiquantitative analysis of composite mixtures of antibodies by native mass spectrometry. , 2012, Analytical chemistry.

[132]  M. Sliwkowski,et al.  Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer , 2011, Clinical Cancer Research.

[133]  Erinc Sahin,et al.  Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms. , 2012, Methods in molecular biology.

[134]  B. Kabakoff,et al.  Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[135]  M. Gerhart,et al.  Characterization of a novel modification on IgG2 light chain. Evidence for the presence of O-linked mannosylation. , 2007, Journal of chromatography. A.

[136]  Scott A. McLuckey,et al.  Differentiation of aspartic and isoaspartic acids using electron transfer dissociation , 2006, Journal of the American Society for Mass Spectrometry.

[137]  N. Bihoreau,et al.  Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry. , 2011, Analytical biochemistry.

[138]  Elevated temperature-extended column length conventional liquid chromatography to increase peak capacity for the analysis of tryptic digests. , 2007, Journal of separation science.

[139]  P. Bondarenko,et al.  Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs , 2008, Journal of the American Society for Mass Spectrometry.

[140]  P. Schnier,et al.  Gas-phase proton-transfer chemistry coupled with TOF mass spectrometry and ion mobility-MS for the facile analysis of poly(ethylene glycols) and PEGylated polypeptide conjugates. , 2008, Analytical chemistry.

[141]  W. Xu,et al.  Disulfide bond assignment of an IgG1 monoclonal antibody by LC-MS with post-column partial reduction. , 2013, Analytical biochemistry.

[142]  J. Rohrer,et al.  Protein variant separations using cation exchange chromatography on grafted, polymeric stationary phases , 2001, Proteomics.

[143]  I. Apostol,et al.  Incorporation of Norvaline at Leucine Positions in Recombinant Human Hemoglobin Expressed in Escherichia coli* , 1997, The Journal of Biological Chemistry.

[144]  D. Farnan,et al.  Multiproduct high-resolution monoclonal antibody charge variant separations by pH gradient ion-exchange chromatography. , 2009, Analytical chemistry.

[145]  Janice M. Reichert,et al.  Marketed therapeutic antibodies compendium , 2012, mAbs.

[146]  K. Ganzler,et al.  Analytical aspects of biosimilarity issues of protein drugs. , 2012, Journal of pharmaceutical and biomedical analysis.

[147]  J. Zhu-Shimoni,et al.  Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1 , 2012, mAbs.

[148]  S. Tuske,et al.  Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking , 2012, Journal of molecular recognition : JMR.

[149]  W. Alley,et al.  Characterization of glycopeptides by combining collision-induced dissociation and electron-transfer dissociation mass spectrometry data. , 2009, Rapid communications in mass spectrometry : RCM.

[150]  Weibin Chen,et al.  Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[151]  François Debaene,et al.  Analytical characterization of biosimilar antibodies and Fc-fusion proteins , 2013 .

[152]  Serge Rudaz,et al.  Analytical strategies for the characterization of therapeutic monoclonal antibodies , 2013 .

[153]  K. Pagel,et al.  Ion mobility-mass spectrometry of complex carbohydrates: collision cross sections of sodiated N-linked glycans. , 2013, Analytical chemistry.

[154]  D. Ejima,et al.  The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals. , 2010, Journal of pharmaceutical sciences.

[155]  Shu-Hui Chen,et al.  A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics. , 2013, Journal of pharmaceutical and biomedical analysis.

[156]  François Debaene,et al.  Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.

[157]  A. Marshall,et al.  Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry. , 2013, Analytical chemistry.

[158]  W. Hancock,et al.  Mass spectrometric determination of disulfide linkages in recombinant therapeutic proteins using online LC-MS with electron-transfer dissociation. , 2009, Analytical chemistry.

[159]  C. Fritsch,et al.  Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab , 2013, BioDrugs.

[160]  P. Bondarenko,et al.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer , 2009, Journal of the American Society for Mass Spectrometry.

[161]  G. Guiochon,et al.  Mass transfer kinetics, band broadening and column efficiency. , 2012, Journal of chromatography. A.

[162]  Milos V Novotny,et al.  Recent trends in analytical and structural glycobiology. , 2013, Current opinion in chemical biology.

[163]  B. Warrack,et al.  Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.

[164]  Min-Yuan Chou,et al.  Automatic disulfide bond assignment using a1 ion screening by mass spectrometry for structural characterization of protein pharmaceuticals. , 2012, Analytical chemistry.

[165]  L. Ilag,et al.  Discrimination among IgG1-κ monoclonal antibodies produced by two cell lines using charge state distributions in nanoESI-TOF mass spectra , 2009, Journal of the American Society for Mass Spectrometry.

[166]  S. Burman,et al.  Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.

[167]  Hongcheng Liu,et al.  Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.

[168]  Gang Xiao,et al.  Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody. , 2008, Journal of pharmaceutical and biomedical analysis.

[169]  Zhongqi Zhang,et al.  Mass spectrometry for structural characterization of therapeutic antibodies. , 2009, Mass spectrometry reviews.

[170]  N. Avdalović,et al.  Analysis of carbohydrates on IgG preparations. , 1994, Journal of pharmaceutical sciences.

[171]  D. Frey,et al.  Monoclonal antibody heterogeneity analysis and deamidation monitoring with high-performance cation-exchange chromatofocusing using simple, two component buffer systems. , 2013, Journal of chromatography. A.

[172]  K. Sandra,et al.  Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[173]  Li Yang,et al.  Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. , 2007, Analytical biochemistry.

[174]  Xinping Fang,et al.  LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. , 2007, Analytical chemistry.

[175]  Rahul S Rajan,et al.  Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. , 2006, Analytical chemistry.

[176]  A. Nava,et al.  Capillary size exclusion chromatography with picogram sensitivity for analysis of monoclonal antibodies purified from harvested cell culture fluid. , 2012, Journal of chromatography. A.

[177]  W. Hancock,et al.  Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator. , 2010, Analytical chemistry.

[178]  Albert J R Heck,et al.  Performing native mass spectrometry analysis on therapeutic antibodies. , 2014, Methods.

[179]  Y. Kao,et al.  On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format. , 2011, Analytical biochemistry.

[180]  Alain Balland,et al.  Characterization of nonenzymatic glycation on a monoclonal antibody. , 2007, Analytical chemistry.

[181]  T. Hayakawa,et al.  Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography--electrospray ionization mass spectrometry. , 2001, Journal of chromatography. A.

[182]  J. V. Van Beeumen,et al.  Characterization of cellobiohydrolase I N-glycans and differentiation of their phosphorylated isomers by capillary electrophoresis-Q-Trap mass spectrometry. , 2004, Analytical chemistry.

[183]  F. Wurm,et al.  Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. , 2011, Analytical chemistry.

[184]  André M Deelder,et al.  IgG glycosylation analysis , 2009, Proteomics.

[185]  B. Yan,et al.  HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[186]  M. Fountoulakis,et al.  Effect of the hydrolysis method on the determination of the amino acid composition of proteins. , 1998, Journal of chromatography. A.

[187]  Jason C Rouse,et al.  Unit mass baseline resolution for an intact 148 kDa therapeutic monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry. , 2011, Analytical chemistry.

[188]  Bruce A Kerwin,et al.  Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. , 2011, Journal of pharmaceutical sciences.

[189]  Qian Wang,et al.  On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product. , 2012, Journal of chromatography. A.

[190]  R. Ionescu,et al.  Fragmentation of monoclonal antibodies , 2011, mAbs.

[191]  C. Eng,et al.  A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) , 2006, Genetics in Medicine.

[192]  Koichi Tanaka,et al.  Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry , 1988 .

[193]  R. O'neill Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis. , 1996, Journal of chromatography. A.

[194]  J. Yoo,et al.  Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. , 2013, Bioanalysis.

[195]  Simona Jevševar,et al.  PEGylation of therapeutic proteins , 2010, Biotechnology journal.

[196]  Darrell Ricke,et al.  Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry. , 2008, Analytical chemistry.

[197]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[198]  Da Ren,et al.  Elucidation of Degradants in Acidic Peak of Cation Exchange Chromatography in an IgG1 Monoclonal Antibody Formed on Long-Term Storage in a Liquid Formulation , 2011, Pharmaceutical Research.

[199]  Pauline M Rudd,et al.  Automated, high-throughput IgG-antibody glycoprofiling platform. , 2013, Analytical chemistry.

[200]  Max Tejada,et al.  Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. , 2012, Analytical chemistry.

[201]  Wolfgang Lindner,et al.  HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals , 2010, Analytical and bioanalytical chemistry.

[202]  D. Ouellette,et al.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule , 2013, mAbs.

[203]  I. Kaltashov,et al.  Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products. , 2011, Current pharmaceutical biotechnology.

[204]  R. Ionescu,et al.  Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. , 2008, Current pharmaceutical biotechnology.

[205]  S. Berkowitz,et al.  Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry , 2010, Journal of the American Society for Mass Spectrometry.

[206]  Jason C Rouse,et al.  Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain. , 2007, Analytical biochemistry.

[207]  E. Ezan,et al.  MS-based approaches for studying the pharmacokinetics of protein drugs. , 2011, Bioanalysis.

[208]  N. Leymarie,et al.  Effective use of mass spectrometry for glycan and glycopeptide structural analysis. , 2012, Analytical chemistry.

[209]  Neil L. Kelleher,et al.  Analysis of Intact Monoclonal Antibody IgG1 by Electron Transfer Dissociation Orbitrap FTMS* , 2012, Molecular & Cellular Proteomics.

[210]  Scott A McLuckey,et al.  Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation. , 2005, Journal of proteome research.

[211]  Rainer Bischoff,et al.  Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[212]  Gerd R Kleemann,et al.  Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. , 2006, Journal of chromatography. A.

[213]  Gang Xiao,et al.  Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments. , 2008, Journal of chromatography. A.

[214]  M. Doyle,et al.  Structural mass spectrometry in protein therapeutics discovery. , 2010, Analytical chemistry.

[215]  I. Kaltashov,et al.  An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins. , 2013, Analytical chemistry.

[216]  M. Fountoulakis,et al.  Hydrolysis and amino acid composition analysis of proteins , 1998 .

[217]  P. Motchnik,et al.  Characterization of monoclonal antibody size variants containing extra light chains , 2013, mAbs.

[218]  B. Devreese,et al.  The Q-trap mass spectrometer, a novel tool in the study of protein glycosylation , 2004, Journal of the American Society for Mass Spectrometry.

[219]  Bettina Bardl,et al.  Simultaneous analysis of the non-canonical amino acids norleucine and norvaline in biopharmaceutical-related fermentation processes by a new ultra-high performance liquid chromatography approach , 2013, Amino Acids.

[220]  Simon J. Henderson,et al.  Monoclonal antibody therapeutics: history and future. , 2012, Current opinion in pharmacology.

[221]  R. Townsend,et al.  Chromatography of carbohydrates , 1988, Nature.

[222]  C. Horváth,et al.  High-speed high-performance liquid chromatography of peptides and proteins. , 1995, Journal of chromatography. A.

[223]  Y. Mechref Analysis of glycans derived from glycoconjugates by capillary electrophoresis‐mass spectrometry , 2011, Electrophoresis.

[224]  A. Vijaya Bhaskar Reddy,et al.  A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance. , 2013, Journal of pharmaceutical and biomedical analysis.